Adage Capital Partners Gp, L.L.C. Seres Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $810,000 - $2.29 Million	-300,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.3 - $8.84 $1.1 Million - $1.55 Million	175,000 Added 140.0%	300,000 $2.14 Million
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $752,500 - $1.43 Million	125,000 New	125,000 $1.04 Million

40.5M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $100M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.